Newly Approved Cell Therapy For Advanced Melanoma, Amtagvi, Is A Potential Breakthrough

A confirmatory Phase 3 trial is ongoing to verify Amtagvi ’s clinical benefit in advanced melanoma patients. If confirmed, Amtagvi will be an important breakthrough.

Source: Forbes.com Healthcare News - March 4, 2024 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news